Literature DB >> 1718182

Pain management in advanced carcinoma of the head and neck.

K D Olsen1, E T Creagan.   

Abstract

Although pain is one of the most feared consequences of cancer, pain management is rarely discussed in the literature on head and neck cancer. The pain experienced by patients with head and neck malignancies, of a biologic origin, is compounded by the emotional distress caused by alterations in function and cosmesis. Control of pain is possible, but an effective program must include more than pain medication. A current treatment program is presented, based on scientific study and clinical experience. The most helpful pain medication is immediate-release, liquid morphine sulfate (20 mg/mL) administered every 4 hours. A nonsteroidal anti-inflammatory drug may also be used and it may decrease the amount of morphine necessary. Stool softeners must be provided, and anti-nausea medication is often given. Steroid drugs are regularly used to increase appetite, decrease edema, and enhance the patient's sense of well-being. Factors related to the selection and dosage of medications are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718182     DOI: 10.1016/0196-0709(91)90146-7

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  2 in total

1.  [Chronic pain therapy for patients with head and neck tumors].

Authors:  A Walz; B Haberland; B Wollenberg; C Bausewein
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

2.  The role of intravenous acetaminophen in post-operative pain control in head and neck cancer patients.

Authors:  Erin Smith; Jessica Lange; Cindy Moore; Isaam Eid; Lana Jackson; Jesus Monico
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.